生物心脏瓣膜移植研究进展

何盛南; 曲龙; 邹志成; 王雨; 邹尚友; 戴一凡; 蔡志明; 黎明涛; 牟丽莎

doi:10.3969/j.issn.1674-7445.2017.05.016

生物心脏瓣膜移植研究进展

doi: 10.3969/j.issn.1674-7445.2017.05.016

510275 广州，中山大学(何盛南、王雨、黎明涛、牟丽莎)；深圳市第二人民医院(何盛南、曲龙、邹志成、王雨、邹尚友、蔡志明、牟丽莎)；南京医科大学(戴一凡)

基金项目:

国家自然科学基金 21602138

广东省自然科学基金 2016A030310032

深圳市卫生计生系统科研项目 201605009

深圳市三名工程；深圳市科创委学科布局项目 JCYJ20160229204849975

深圳市科创委企业工程中心项目 GCZX2015043017281705

深圳市高水平医学学科建设专项基金 2016031638

详细信息

通讯作者:
牟丽莎, Email:molly_molly@163.com

中图分类号: R617;R654.2
计量
- 文章访问数: 228
- HTML全文浏览量: 282
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2017-06-21
- 网络出版日期: 2021-01-19
- 刊出日期: 2017-09-15

摘要

摘要: 心脏瓣膜移植手术已在临床开展50余年，全球开展了大量研究以提高生物心脏瓣膜移植的成功率。本文主要对机械瓣膜与生物瓣膜的选择、戊二醛固定的生物心脏瓣膜的优势及存在的问题、转基因猪心脏瓣膜的应用价值进行综述。
- 生物心脏瓣膜 /
- 异种移植 /
- 免疫排斥反应 /
- 钙化 /
- α-1, 3-半乳糖 /
- 心脏瓣膜置换 /
- 转基因猪 /
- 基因敲除 /
- 戊二醛 /
- N-羟乙酰神经氨酸

HTML全文

参考文献(30)

[1]	Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves:modes of failure[J]. Histopathology, 2009, 55(2):135-144. DOI: 10.1111/j.1365-2559.2008.03190.x.
[2]	Etz CD, Girrbach FF, Von Aspern K, et al. Longevity after aortic root replacement is the mechanically valved conduit really the gold standard for quinquagenarians?[J]. Circulation, 2013, 128(11 Suppl 1):S253-S262. DOI: 10.1161/CIRCULATIONAHA.112.000338.
[3]	Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes:progress toward understanding and prevention[J]. Ann Thorac Surg, 2005, 79(3):1072-1080. doi: 10.1016/j.athoracsur.2004.06.033
[4]	Butany J, Zhou T, Leong SW, et al. Inflammation and infection in nine surgically explanted medtronic freestyle stentless aortic valves[J]. Cardiovasc Pathol, 2007, 16(5):258-267. doi: 10.1016/j.carpath.2007.01.009
[5]	Zhao DF, Seco M, Wu JJ, et al. Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults:a systematic review and Metaanalysis[J]. Ann Thorac Surg, 2016, 102(1):315-327. DOI: 10.1016/j.athoracsur.2015.10.092.
[6]	Barros JA, Filippin-Monteiro FB, de Oliveira EM, et al. Cytotoxicity of PVPAC-treated bovine pericardium:a potential replacement for glutaraldehyde in biological heart valves[J]. J Biomed Mater Res B Appl Biomater, 2014, 102(3):574-582. DOI: 10.1002/jbm.b.33036.
[7]	Cho HJ, Cho HJ, Kim HS. Osteopontin:a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification[J]. Curr Atheroscler Rep, 2009, 11(3):206-213. doi: 10.1007/s11883-009-0032-8
[8]	Wilhelmi MH, Mertsching H, Wilhelmi M, et al. Role of inflammation in allogeneic and xenogeneic heart valve degeneration:immunohistochemical evaluation of inflammatory endothelial cell activation[J]. J Heart Valve Dis, 2003, 12(4):520-526.
[9]	Basaraba RJ, Bielefeldt-Ohmann H, Eschelbach EK, et al. Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig[J]. Tuberculosis (Edinb), 2008, 88(1):69-79. doi: 10.1016/j.tube.2007.09.002
[10]	Chang Q, Jing H, Sun M, et al. Exploring the role of short-course cyclosporin a therapy in preventing homograft valve calcification after transplantation[J]. Cell Immunol, 2014, 287(1):36-45. DOI: 10.1016/j.cellimm.2013.11.008.
[11]	Manji RA, Ekser B, Menkis AH, et al. Bioprosthetic heart valves of the future[J]. Xenotransplantation, 2014, 21(1):1-10. DOI:10.1111/xen.12080. Epub 2014 Jan 21.
[12]	Hülsmann J, Grün K, El Amouri S, et al. Transplantation material bovine pericardium:biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing[J]. Xenotransplantation, 2012, 19(5):286-297. DOI: 10.1111/j.1399-3089.2012.00719.x.
[13]	Simionescu DT. Prevention of calcification in bioprosthetic heart valves:challenges and perspectives[J]. Expert Opin Biol Ther, 2004, 4(12):1971-1985. doi: 10.1517/14712598.4.12.1971
[14]	Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans[J]. Nat Med, 1995, 1(9):964-966. doi: 10.1038/nm0995-964
[15]	Huai G, Qi P, Yang H, et al. Characteristics of α-Gal epitope, anti-Gal antibody, α1, 3 galactosyltransferase and its clinical exploitation (review)[J]. Int J Mol Med, 2016, 37(1):11-20. DOI: 10.3892/ijmm.2015.2397.
[16]	Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1, 3-galactosyltransferase -deficient pigs[J]. Science, 2003, 299(5605):411-414. doi: 10.1126/science.1078942
[17]	Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha 1, 3-galactosyltransferase gene-knockout pigs as donors:initial experience[J]. Nat Med, 2005, 11(1):29-31. doi: 10.1038/nm1171
[18]	McGregor CG, Carpentier A, Lila N, et al. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves[J]. J Thorac Cardiovasc Surg, 2011, 141(1):269-275. DOI: 10.1016/j.jtcvs.2010.08.064.
[19]	Lila N, McGregor CG, Carpentier S, et al. Gal knockout pig pericardium:new source of material for heart valve bioprostheses[J]. J Heart Lung Transplant, 2010, 29(5):538-543. DOI: 10.1016/j.healun.2009.10.007.
[20]	Springer SA, Diaz SL, Gagneux P. Parallel evolution of a self-signal:humans and new world monkeys independently lost the cell surface sugar Neu5Gc[J]. Immunogenetics, 2014, 66(11):671-674. DOI: 10.1007/s00251-014-0795-0.
[21]	Samraj AN, Pearce OM, Laubli H, et al. A red meat-derived glycan promotes inflammation and cancer progression[J]. Proc Natl Acad Sci U S A, 2015, 112(2):542-547. DOI: 10.1073/pnas.1417508112.
[22]	Lee W, Hara H, Ezzelarab MB, et al. Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs[J]. Xenotransplantation, 2016, 23(2):137-150. DOI: 10.1111/xen.12229.
[23]	Scobie L, Padler-Karavani V, Le Bas-Bernardet S, et al. Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts[J]. J Immunol, 2013, 191(6):2907-2915. DOI: 10.4049/jimmunol.1301195.
[24]	Salama A, Evanno G, Harb J, et al. Potential deleterious role of antiNeu5Gc antibodies in xenotransplantation[J]. Xenotransplantation, 2015, 22(2):85-94. DOI: 10.1111/xen.12142.
[25]	Lutz AJ, LiP, Estrada JL, et al. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1, 3-galactose reduce the humoral barrier to xenotransplantation[J]. Xenotransplantation, 2013, 20(1):27-35. DOI: 10.1111/xen.12019.
[26]	Cooper DK, Ekser B, Burlak C, et al. Clinical lung xenotransplantation-what donor genetic modifications may be necessary?[J]. Xenotransplantation, 2012, 19(3):144-158. DOI: 10.1111/j.1399-3089.2012.00708.x.
[27]	Sachs DH, Galli C. Genetic manipulation in pigs[J]. Curr Opin Organ Transplant, 2009, 14(2):148-153. doi: 10.1097/MOT.0b013e3283292549
[28]	Mohiuddin MM, Singh AK, Corcoran PC, et al. Chimeric 2C10R4 antiCD40 antibody therapy is critical for long-term survival of GTKO. hCD46.hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016, 7:11138. DOI: 10.1038/ncomms11138.
[29]	Niemann H, and Petersen B. The production of multi-transgenic pigs:update and perspectives for xenotransplantation[J]. Transgenic Res, 2016, 25(3):361-374. DOI: 10.1007/s11248-016-9934-8.
[30]	Yang L, Güell M, Niu D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs)[J]. Science, 2015, 350(6264):1101-1104. DOI: 10.1126/science.aad1191.